Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06467292 · ClinicalTrials.gov registry record · NA
Speech Motor Learning and Retention (Master Protocol)
A NA study of Speech, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 330
- Enrollment target
- 1
- Study location
NCT06467292: Recruiting NA study of Speech, sponsored by Yale University.
NCT06467292 is a NA study of Speech that is actively recruiting participants, run by Yale University. The registered enrollment target is 330 participants, above the 139-participant average among 9 other Speech trials with a reported enrollment target (137% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06467292, a NA study of Speech, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 330 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this research is to test a new model of speech motor learning, whose central hypothesis is that learning and retention are associated with plasticity not only in motor areas of the brain but in auditory and somatosensory regions as well.
Primary Outcome
Audapter software will be used to alter the first and second formant frequencies of the spoken words and this is played back to subjects through headphones. Subjects will be tested both with unaltered feedback and with abruptly introduced frequency shifts.The change in the first (F1) and second format frequency (F2) values will be assessed using Praat.
Conditions Studied
Interventions
- DEVICE fMRI
- DEVICE continuous theta-burst stimulation (cTBS)
- BEHAVIORAL Adaptation
- DEVICE Single pulse Transcranial magnetic stimulation (TMS)
Study Locations (1)
Connecticut
- Yale Child Study Center - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2029-05-31 |
| Phase | NA |
What NCT06467292 shows while recruiting
NCT06467292 is an interventional study that assigns participants to a tested intervention. The registered 330 participants enrollment target is mid-sized for trials with a published cap, above the 139-participant average among 9 other Speech trials with a reported enrollment target (137% higher).
The record links to 1 condition, with Speech appearing as the primary indexed condition, and to 4 interventions - of which fMRI is the first listed.
NCT06467292 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT06467292 about?
NCT06467292 is a clinical study titled "Speech Motor Learning and Retention (Master Protocol)". The overall goal of this research is to test a new model of speech motor learning, whose central hypothesis is that learning and retention are associated with plasticity not only in motor areas of the brain but in auditory and somatosensory regions as well.
What is the current status of trial NCT06467292?
This trial is currently recruiting. It is a NA study. The enrollment target is 330 participants. The study started on 2024-10-01. Estimated completion is 2029-05-31.
What conditions does trial NCT06467292 study?
This clinical trial studies the following conditions: Speech.
What interventions are being tested in trial NCT06467292?
The interventions under investigation include: fMRI (DEVICE), continuous theta-burst stimulation (cTBS) (DEVICE), Adaptation (BEHAVIORAL), Single pulse Transcranial magnetic stimulation (TMS) (DEVICE).
Who is sponsoring clinical trial NCT06467292?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06467292 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Speech
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06467292's enrollment target sits among peer trials
330 2nd of 9 the highest of 9 other Speech trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Speech trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Vowel Space Expansion Sensorimotor Adaptation
RECRUITING · NA
-
Speech Motor Learning and Retention (Aim 1)
RECRUITING · NA
-
Speech Motor Learning and Retention (Aim 2)
RECRUITING · NA
-
Effects of Clear Speech on Listening Effort and Memory in Sentence Processing
RECRUITING · NA
-
Talk With Me Baby to Enhance the Early Home Language Environment
RECRUITING · NA
-
Behavioral and Neural Characteristics of Adaptive Speech Motor Control
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00359684 · 330 participants
Use of Cysteamine in the Treatment of Cystinosis
- NCT03817502 · 330 participants · Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- NCT03922724 · 330 participants · Phase 2
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
- NCT03932773 · 330 participants · NA
Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI